AAOS Results Recap: Stryker’s Knee-Surgery Robot And Miach’s New ACL Scaffold
Medtech Insight's Results Recap covers major device trial results appearing on MedDeviceTracker. This is a special edition covering trial data presented during the first three days of the American Academy of Orthopedic Surgeons Annual Meeting, held in Las Vegas March 12-16, including presentations on devices from Stryker, Miach, Myoscience, CyMedica, and Reflexion Health.
You may also be interested in...
Miach Orthopedics expects to soon earn US FDA de novo clearance for its Bridge-Enhanced ACL Repair (BEAR) technology as an alternative to conventional anterior cruciate ligament reconstruction surgery. Trials have shown BEAR helps restore torn ACLs to normal strength and function.
Stryker reported organic growth of 8.5% during the second quarter of 2019 led by 12% growth in the medical and surgical equipment business, 7% growth in neurotechnology and spine revenue, and 6% growth in sales of orthopedic devices, led by the Mako robotic surgery system.
Johnson & Johnson’s leadership remains optimistic about the future of its medical device divisions despite reporting a 2.6% revenue decline in the first six months of 2019 compared to the same period of 2018.